PYPD
PYPD
NASDAQ · Pharmaceuticals

Polypid Ltd

$5.04
+0.30 (+6.33%)
As of Jun 22, 5:05 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +648.2% upside
Low Target $24.55
Average Target $37.71
High Target $48.03
Current Price $5.04
Current
$5.04
Target
$37.71
$24.55 $37.71 avg $48.03
Scenario Analysis
Bear Case
$24.55
387.1%
Low target
Base Case
$37.71
+648.2%
Avg target
Bull Case
$48.03
+853.0%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$5.21
-3.3% from high
52-Week Low
$3.06
+64.7% from low
Target vs 52W High
$37.71
+623.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%